Medline Statistics

Total Valuation

Medline has a market cap or net worth of $51.06 billion. The enterprise value is $61.43 billion.

Market Cap	51.06B
Enterprise Value	61.43B

Important Dates

The last earnings date was Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Medline has 1.31 billion shares outstanding.

Current Share Class	845.61M
Shares Outstanding	1.31B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.83%
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	49.02%
Float	356.91M

Valuation Ratios

The trailing PE ratio is 34.04 and the forward PE ratio is 25.21. Medline's PEG ratio is 5.43.

PE Ratio	34.04
Forward PE	25.21
PS Ratio	1.75
Forward PS	1.62
PB Ratio	2.92
P/TBV Ratio	n/a
P/FCF Ratio	51.27
P/OCF Ratio	34.64
PEG Ratio	5.43

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.18, with an EV/FCF ratio of 61.68.

EV / Earnings	63.59
EV / Sales	2.11
EV / EBITDA	20.18
EV / EBIT	30.32
EV / FCF	61.68

Financial Position

The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.65.

Current Ratio	4.41
Quick Ratio	2.34
Debt / Equity	0.65
Debt / EBITDA	3.98
Debt / FCF	12.69
Interest Coverage	2.34

Financial Efficiency

Return on equity (ROE) is 6.05% and return on invested capital (ROIC) is 6.04%.

Return on Equity (ROE)	6.05%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.04%
Return on Capital Employed (ROCE)	5.55%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$647,556
Profits Per Employee	$21,467
Employee Count	45,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Medline has paid $127.00 million in taxes.

Income Tax	127.00M
Effective Tax Rate	10.57%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	39.31
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.04
Average Volume (20 Days)	11,996,791

Short Selling Information

The latest short interest is 27.64 million, so 2.10% of the outstanding shares have been sold short.

Short Interest	27.64M
Short Previous Month	22.77M
Short % of Shares Out	2.10%
Short % of Float	7.75%
Short Ratio (days to cover)	1.96

Income Statement

In the last 12 months, Medline had revenue of $29.14 billion and earned $966.00 million in profits. Earnings per share was $1.14.

Revenue	29.14B
Gross Profit	7.54B
Operating Income	2.03B
Pretax Income	1.20B
Net Income	966.00M
EBITDA	3.04B
EBIT	2.03B
Earnings Per Share (EPS)	$1.14

Full Income Statement

Balance Sheet

The company has $2.27 billion in cash and $12.64 billion in debt, giving a net cash position of -$10.37 billion or -$7.89 per share.

Cash & Cash Equivalents	2.27B
Total Debt	12.64B
Net Cash	-10.37B
Net Cash Per Share	-$7.89
Equity (Book Value)	19.35B
Book Value Per Share	13.32
Working Capital	8.64B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.47 billion and capital expenditures -$478.00 million, giving a free cash flow of $996.00 million.

Operating Cash Flow	1.47B
Capital Expenditures	-478.00M
Depreciation & Amortization	1.02B
Net Borrowing	-4.13B
Free Cash Flow	996.00M
FCF Per Share	$0.76

Full Cash Flow Statement

Margins

Gross margin is 25.86%, with operating and profit margins of 6.95% and 3.32%.

Gross Margin	25.86%
Operating Margin	6.95%
Pretax Margin	4.12%
Profit Margin	3.32%
EBITDA Margin	10.45%
EBIT Margin	6.95%
FCF Margin	3.42%

Dividends & Yields

Medline does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.89%
FCF Yield	1.95%

Analyst Forecast

The average price target for Medline is $51.15, which is 31.59% higher than the current price. The consensus rating is "Buy".

Price Target	$51.15
Price Target Difference	31.59%
Analyst Consensus	Buy
Analyst Count	28
Revenue Growth Forecast (3Y)	8.23%
EPS Growth Forecast (3Y)	1.58%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medline has an Altman Z-Score of 2.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.29
Piotroski F-Score	3